HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-07

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood Pressure Monitoring in Postpartum Women at Risk of Hypertension

NCT05457504

Hypertension in Pregnancy Preeclampsia Gestational Hypertension +2 more

UNKNOWN NA

Remote BP Monitoring in the PP Period

NCT03728790

Hypertensive Disorder of Pregnancy

COMPLETED NA

Remote Surveillance of Postpartum Hypertension

NCT03185455

Hypertension in Pregnancy

COMPLETED NA

Wearables to Define Postpartum Blood Pressure Trajectories and Facilitate Evidence-based Monitoring Guidelines

NCT06576544

Hypertension, Pregnancy-Induced Hypertension Postpartum Preeclampsia +5 more

ENROLLING_BY_INVITATION

Enhancing Care & Outcomes for Patients During the First Postpartum Year

NCT06615076

Postpartum Period Pregnancy Hypertension, Pregnancy Induced

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Hypertension Hypertensive Disorder of Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2-Week Arm

Participants randomized into the 2 week arm will be immediately unenrolled from the postpartum remote blood pressure monitoring program and resume standard postpartum care

Group Type ACTIVE_COMPARATOR

2-Week Home Monitoring

Intervention Type DIAGNOSTIC_TEST

Those who are randomized into the 2-week intervention arm will be unenrolled from the postpartum remote blood pressure monitoring program and therefore will no longer be transmitting twice daily blood pressures for review.

6-Week Arm

Patients randomized into the 6 week arm will continue and complete the program in its entirety per current SOC (4 additional weeks)

Group Type ACTIVE_COMPARATOR

6-Week Home Monitoring

Intervention Type DIAGNOSTIC_TEST

HOPE-BP provides remote monitoring for the 35% of approximately 2,800 annual births at our institution complicated by HDP. Eligible patients enroll at hospital discharge into a 6-week program, submitting blood pressure readings twice daily via Epic's MyChart Care Companion. Participants receive immediate automated feedback, and a dedicated Maternal Fetal Medicine nursing team reviews data daily (Monday-Friday, 8 AM-4 PM), initiating or adjusting antihypertensive therapy as needed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2-Week Home Monitoring

Those who are randomized into the 2-week intervention arm will be unenrolled from the postpartum remote blood pressure monitoring program and therefore will no longer be transmitting twice daily blood pressures for review.

Intervention Type DIAGNOSTIC_TEST

6-Week Home Monitoring

HOPE-BP provides remote monitoring for the 35% of approximately 2,800 annual births at our institution complicated by HDP. Eligible patients enroll at hospital discharge into a 6-week program, submitting blood pressure readings twice daily via Epic's MyChart Care Companion. Participants receive immediate automated feedback, and a dedicated Maternal Fetal Medicine nursing team reviews data daily (Monday-Friday, 8 AM-4 PM), initiating or adjusting antihypertensive therapy as needed.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Discharged after delivery at University of Minnesota Medical Center
* Enrolled into the HOPE-BP Program

Exclusion Criteria

* Ongoing antihypertensive medication use at 2 weeks (time of randomization)
* Have a medical comorbidity that would not be clinically appropriate to randomize
* Patients opted out of clinical research

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No